The Efficacy and Safety of Traditional Chinese Medicine (Jiang Zhi Granule) for Nonalcoholic Fatty Liver: A Multicenter, Randomized, Placebo-Controlled Study

Table 1

Baseline characteristics of patients (FAS analysis).

Parameter	JZG (𝑛=111)	Placebo (𝑛=110)	𝑃
Age, y	42.39±11.55	44.82±11.41	0.1178
Male sex, 𝑛 (%)	94 (84.68)	83 (75.45)	0.0858
Weight (male), kg	78.87±10.38	79.43±10.70	0.7280
Weight (female), kg	63.22±7.32	64.49±9.50	0.5334
Systolic pressure, mmHg/L	124.44±8.98	122.21±9.40	0.0724
Diastolic pressure, mmHg/L	77.69±6.52	77.18±6.96	0.5732
L/S ratio	0.74±0.21	0.79±0.18	0.0856
BMI	26.85±3.34	26.69±2.78	0.6994
Course of NAFL, month	26.61±29.29	30.02±34.59	0.6004
Comorbidity (with), 𝑛 (%)	4 (3.60)	4 (3.64)	1.0000
History of drug hypersensitivity (yes), 𝑛 (%)	2 (1.80)	1 (0.91)	n.s.
Combined medicine using (yes), 𝑛 (%)	2 (1.82)	3 (2.73)	n.s.
Serum glucose, mmol/L	5.54±0.37	5.27±0.64	1.0000
ALT, IU/L	41.22±19.48	42.61±20.85	>0.05
AST, IU/L	32.99±12.76	32.92±13.31	>0.05
BUN, mmol/L	5.59±6.76	8.91±3.90	>0.05
Serum Cr, 𝜇mol/L	79.84±20.19	77.82±17.24	>0.05

Data were presented as mean ± standard deviation.